Key points are not available for this paper at this time.
As compared with placebo, intravenous alteplase administered between 3 and 4.5 hours after the onset of symptoms significantly improved clinical outcomes in patients with acute ischemic stroke; alteplase was more frequently associated with symptomatic intracranial hemorrhage. (ClinicalTrials.gov number, NCT00153036.)
Building similarity graph...
Analyzing shared references across papers
Loading...
Hacke et al. (Wed,) studied this question.
www.synapsesocial.com/papers/699b98657013ecf4b527cc5f — DOI: https://doi.org/10.1056/nejmoa0804656
Werner Hacke
Markku Kaste
Erich Bluhmki
New England Journal of Medicine
Karolinska Institutet
Heidelberg University
University of Glasgow
Building similarity graph...
Analyzing shared references across papers
Loading...